2020
DOI: 10.1111/ecc.13370
|View full text |Cite
|
Sign up to set email alerts
|

A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: A healthcare provider’s view

Abstract: Breast, prostate and colorectal cancer are among the most prevalent cancers worldwide, with over 6.5 million breast cancer survivors, almost 4 million prostate cancer survivors and over 4.5 million colorectal cancer survivors within 5 years of diagnosis (GLOBOCAN, 2018). A substantial proportion of these patients experience long-term and late effects of cancer, and their management should be one of the cornerstones of cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
9
0
4

Year Published

2021
2021
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 48 publications
(78 reference statements)
2
9
0
4
Order By: Relevance
“…This result also was similar to Martin et al, (2020) who carried out a study on "A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: A healthcare provider's view" and found that three quarters of the nurses were female.…”
Section: Demographic Datasupporting
confidence: 84%
“…This result also was similar to Martin et al, (2020) who carried out a study on "A qualitative evaluation of the use of interventions to treat fatigue among cancer survivors: A healthcare provider's view" and found that three quarters of the nurses were female.…”
Section: Demographic Datasupporting
confidence: 84%
“…Cancer-related fatigue is one of the most prevalent symptoms patients suffer both during and after treatment [ 13 , 14 ], affecting 50–90% of all cases [ 14 , 15 , 16 ]. Fatigue appears regardless of age, sex, type of cancer, stage of disease, and treatment modality [ 15 , 17 , 18 ] and can become persistent, thereby limiting QoL and the activities of daily life for years [ 13 , 14 , 16 ]. Moreover, cancer-associated fatigue is unlike the exhaustion that most people experience as a result of their daily activities, inasmuch as it is not proportional to the level of effort and rest or sleep fail to remedy it [ 14 , 18 ].…”
Section: Introductionmentioning
confidence: 99%
“…Malignancy patients suffering from treatment and/or disease progression also suffer from cancer-related fatigue, which is a vexing issue. Management strategies for CRF are currently poorly understood, and the benefits of some pharmacological treatments and exercise-based interventions are relatively modest [18]. Although the etiology of CRF has been studied for nearly two decades, to date, there have been no large-scale, randomized, double-blind clinical trials to confirm the effectiveness of intervention methods.…”
Section: Discussionmentioning
confidence: 99%